Access to Treatment for Opioid Use Disorder: Highlights from Recent Grantee Publications

Over the past five years, FORE-funded researchers have documented the administrative, financial, and logistical barriers patients face in obtaining medications for opioid use disorder (MOUD), such as buprenorphine and methadone, and highlighted opportunities to broaden access through pharmacies, emergency departments, primary care offices, and other health care settings. This data brief highlights findings from their recent publications, which suggest new pathways for enhancing access to lifesaving medications.